TMC-GCID Publications

Found 11 results
Filters: Author is Ramani, Sasirekha  [Clear All Filters]
2026
Kaur G, Crawford SE, Cregeen SJavornik, Surathu A, B Ayyar VV, Apostol CV, et al.. Overcoming host restrictions to enable continuous passaging of GII.3 human norovirus in human intestinal enteroids. Sci Adv. 2026. p. eaeb0455.
2025
Bhamidipati SV, Surathu A, Chao H, Agustinho DP, Xiang Q, Kottapalli K, et al.. Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 ;15(1):20526.
2024
Lewis MA, Patil K, Ettayebi K, Estes MK, Atmar RL, Ramani S. Divergent responses of human intestinal organoid monolayers using commercial in vitro cytotoxicity assays. PLoS One. 2024 ;19(6):e0304526.
Adeniyi-Ipadeola GO, Hankins JD, Kambal A, Zeng X-L, Patil K, Poplaski V, et al.. Infant and adult human intestinal enteroids are morphologically and functionally distinct. mBio. 2024 ;15(8):e0131624.
Ramani S, Cregeen SJJavornik, Surathu A, Neill FH, Muzny DM, Doddapaneni H, et al.. INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS. bioRxiv. 2024 ;.
2023
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 ;67(10):e0063623.
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 ;.
2021
Criss ZK, Bhasin N, Di Rienzi SC, Rajan A, Deans-Fielder K, Swaminathan G, et al.. Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 ;53(11):486-508.
Chen F, Zhang Y, Sucgang R, Ramani S, Corry D, Kheradmand F, et al.. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors. Sci Rep. 2021 ;11(1):2459.
Kondapi DSamantha, Ramani S, Estes MK, Atmar RL, Okhuysen PC. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis. 2021 ;8(6):ofab126.
2020
Lin S-C, Qu L, Ettayebi K, Crawford SE, Blutt SE, Robertson MJ, et al.. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 ;117(38):23782-23793.